Longitudinal trajectories of cognitive decline among older adults with cardiovascular disease

Cerebrovascular Diseases

Volumn 30, Issue 4, 2010, Pages 362-373

  Okonkwo, Ozioma C ^a   Cohen, Ronald A ^b   Gunstad, John ^d   Tremont, Geoffrey ^b,c   Alosco, Michael L ^c   Poppas, Athena ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BROWN UNIVERSITY   (United States)

^c RHODE ISLAND HOSPITAL   (United States)

^d KENT STATE UNIVERSITY   (United States)

Author keywords

Cardiovascular disease; Cognitive decline; Vascular cognitive impairment

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN FUNCTION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COGNITIVE DEFECT; DEPTH PERCEPTION; DISEASE COURSE; FEMALE; GERIATRICS; HEART FAILURE; HEART SURGERY; HUMAN; LANGUAGE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEMORY; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCHOMOTOR PERFORMANCE; VASCULAR COGNITIVE IMPAIRMENT;

AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; COGNITION DISORDERS; COHORT STUDIES; CORONARY ARTERY BYPASS; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS;

EID: 77955197588     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000319564     Document Type: Article

References (87)

1. Rao R, Howard R: Vascular dementia: dead or alive? Int J Geriatr Psychiatry 1998;13:277-284.
2. Duron E, Hanon O: Vascular risk factors, cognitive decline, and dementia. Vasc Health Risk Manag 2008;4:363-381.
3. Leblanc GG, Meschia JF, Stuss DT, Hachinski V: Genetics of vascular cognitive impairment: the opportunity and the challenges. Stroke 2006;37:248-255.
4. Cohen RA, Moser DJ, Clark MM, Aloia MS, Cargill BR, Stefanik S, Albrecht A, Tilkemeier P, Forman DE: Neurocognitive functioning and improvement in quality of life following participation in cardiac rehabilitation. Am J Cardiol 1999;83:1374-1378.
5. Rockwood K, Wentzel C, Hachinski V, Hogan DB, MacKnight C, McDowell I: Prevalence and outcomes of vascular cognitive impairment. Vascular Cognitive Impairment Investigators of the Canadian Study of Health and Aging. Neurology 2000;54:447-451.
6. Hachinski V, Iadecola C, Petersen RC, Breteler MM, Nyenhuis DL, Black SE, Powers WJ, DeCarli C, Merino JG, Kalaria RN, Vinters HV, Holtzman DM, Rosenberg GA, Wallin A, Dichgans M, Marler JR, Leblanc GG: National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards. Stroke 2006;37:2220-2241.
7. O'Brien JT, Erkinjuntti T, Reisberg B, Roman G, Sawada T, Pantoni L, Bowler JV, Ballard C, DeCarli C, Gorelick PB, Rockwood K, Burns A, Gauthier S, DeKosky ST: Vascular cognitive impairment. Lancet Neurol 2003;2:89-98.
8. Desmond DW: The neuropsychology of vascular cognitive impairment: is there a specific cognitive deficit? J Neurol Sci 2004;226:3-7.
9. Hachinski V: Vascular dementia: a radical redefinition. Dementia 1994;5:130-132.
10. O'Brien JT: Vascular cognitive impairment. Am J Geriatr Psychiatry 2006;14:724-733.
11. Sachdev PS, Brodaty H, Valenzuela MJ, Lorentz L, Looi JC, Wen W, Zagami AS: The neuropsychological profile of vascular cognitive impairment in stroke and TIA patients. Neurology 2004;62:912-919.
12. Garrett KD, Browndyke JN, Whelihan W, Paul RH, DiCarlo M, Moser DJ, Cohen RA, Ott BR: The neuropsychological profile of vascular cognitive impairment - no dementia: comparisons to patients at risk for cerebrovascular disease and vascular dementia. Arch Clin Neuropsychol 2004;19:745-757.
13. Nyenhuis DL, Gorelick PB, Geenen EJ, Smith CA, Gencheva E, Freels S, DeToledo-Morrell L: The pattern of neuropsychological deficits in Vascular Cognitive Impairment-No Dementia (Vascular CIND). Clin Neuropsychol 2004;18:41-49.
14. Alexander GE, DeLong MR, Strick PL: Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci 1986;9:357-381.
15. Pantoni L, Poggesi A, Inzitari D: Cognitive decline and dementia related to cerebrovascular diseases: some evidence and concepts. Cerebrovasc Dis 2009;27(suppl 1):191-196.
16. Tate DF, Jefferson AL, Brickman AM, Hoth KF, Gunstad J, Bramley K, Paul RH, Poppas A, Cohen RA: Regional white matter signal abnormalities and cognitive correlates among geriatric patients with treated cardiovascular disease. Brain Imaging Behav 2008;2:200-206.
17. Paglieri C, Bisbocci D, Caserta M, Rabbia F, Bertello C, Canade A, Veglio F: Hypertension and cognitive function. Clin Exp Hypertens 2008;30:701-710.
18. Kivipelto M, Ngandu T, Fratiglioni L, Viitanen M, Kareholt I, Winblad B, Helkala EL, Tuomilehto J, Soininen H, Nissinen A: Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease. Arch Neurol 2005;62:1556-1560.
19. Jefferson AL, Poppas A, Paul RH, Cohen RA: Systemic hypoperfusion is associated with executive dysfunction in geriatric cardiac patients. Neurobiol Aging 2007;28:477-483.
20. Jerskey BA, Cohen RA, Jefferson AL, Hoth KF, Haley AP, Gunstad JJ, Forman DE, Sweet LH, Poppas A: Sustained attention is associated with left ventricular ejection fraction in older adults with heart disease. J Int Neuropsychol Soc 2009;15:137-141.
21. Cohen RA, Poppas A, Forman DE, Hoth KF, Haley AP, Gunstad J, Jefferson AL, Tate DF, Paul RH, Sweet LH, Ono M, Jerskey BA, Gerhard-Herman M: Vascular and cognitive functions associated with cardiovascular disease in the elderly. J Clin Exp Neuropsychol 2008;31:96-110.
22. Haley AP, Forman DE, Poppas A, Hoth KF, Gunstad J, Jefferson AL, Paul RH, Ler AS, Sweet LH, Cohen RA: Carotid artery intimamedia thickness and cognition in cardiovascular disease. Int J Cardiol 2007;121:148-154.
23. Haley AP, Sweet LH, Gunstad J, Forman DE, Poppas A, Paul RH, Tate DF, Cohen RA: Verbal working memory and atherosclerosis in patients with cardiovascular disease: an fMRI study. J Neuroimaging 2007;17:227-233.
24. Hoth KF, Haley AP, Gunstad J, Paul RH, Poppas A, Jefferson AL, Tate DF, Ono M, Jerskey BA, Cohen RA: Elevated C-reactive protein is related to cognitive decline in older adults with cardiovascular disease. J Am Geriatr Soc 2008;56:1898-1903.
25. Gunstad J, Poppas A, Smeal S, Paul RH, Tate DF, Jefferson AL, Forman DE, Cohen RA: Relation of brain natriuretic peptide levels to cognitive dysfunction in adults 1 55 years of age with cardiovascular disease. Am J Cardiol 2006;98:538-540.
26. Gunstad J, Bausserman L, Paul RH, Tate DF, Hoth K, Poppas A, Jefferson AL, Cohen RA: C-reactive protein, but not homocysteine, is related to cognitive dysfunction in older adults with cardiovascular disease. J Clin Neurosci 2006;13:540-546.
27. de Jager CA: Changes over time in memory, processing speed and clock drawing tests help to discriminate between vascular cognitive impairment, mild cognitive impairment and Alzheimer's disease. Neurol Res 2004;26:481-487.
28. Wentzel C, Rockwood K, MacKnight C, Hachinski V, Hogan DB, Feldman H, Ostbye T, Wolfson C, Gauthier S, Verreault R, Mc-Dowell I: Progression of impairment in patients with vascular cognitive impairment without dementia. Neurology 2001;57:714-716.
29. Stanek KM, Gunstad J, Paul RH, Poppas A, Jefferson AL, Sweet LH, Hoth KF, Haley AP, Forman DE, Cohen RA: Longitudinal cognitive performance in older adults with cardiovascular disease: evidence for improvement in heart failure. J Cardiovasc Nurs 2009;24:192-197.
30. Selnes OA, Grega MA, Bailey MM, Pham LD, Zeger SL, Baumgartner WA, McKhann GM: Cognition 6 years after surgical or medical therapy for coronary artery disease. Ann Neurol 2008;63:581-590.
31. Cohen RA, Poppas A, Forman DE, Hoth KF, Haley AP, Gunstad J, Jefferson AL, Tate DF, Paul RH, Sweet LH, Ono M, Jerskey BA, Gerhard-Herman M: Vascular and cognitive functions associated with cardiovascular disease in the elderly. J Clin Exp Neuropsychol 2008;31:96-110.
32. Haley AP, Forman DE, Poppas A, Hoth KF, Gunstad J, Jefferson AL, Paul RH, Ler AS, Sweet LH, Cohen RA: Carotid artery intimamedia thickness and cognition in cardiovascular disease. Int J Cardiol 2007;121:148-154.
33. Haley AP, Sweet LH, Gunstad J, Forman DE, Poppas A, Paul RH, Tate DF, Cohen RA: Verbal working memory and atherosclerosis in patients with cardiovascular disease: an fMRI study. J Neuroimaging 2007;17:227-233.
34. Hoth KF, Haley AP, Gunstad J, Paul RH, Poppas A, Jefferson AL, Tate DF, Ono M, Jerskey BA, Cohen RA: Elevated C-reactive protein is related to cognitive decline in older adults with cardiovascular disease. J Am Geriatr Soc 2008;56:1898-1903.
35. Gunstad J, Poppas A, Smeal S, Paul RH, Tate DF, Jefferson AL, Forman DE, Cohen RA: Relation of brain natriuretic peptide levels to cognitive dysfunction in adults 155 years of age with cardiovascular disease. Am J Cardiol 2006;98:538-540.
36. Gunstad J, Bausserman L, Paul RH, Tate DF, Hoth K, Poppas A, Jefferson AL, Cohen RA: C-reactive protein, but not homocysteine, is related to cognitive dysfunction in older adults with cardiovascular disease. J Clin Neurosci 2006;13:540-546.
37. de Jager CA: Changes over time in memory, processing speed and clock drawing tests help to discriminate between vascular cognitive impairment, mild cognitive impairment and Alzheimer's disease. Neurol Res 2004;26:481-487.
38. Wentzel C, Rockwood K, MacKnight C, Hachinski V, Hogan DB, Feldman H, Ostbye T, Wolfson C, Gauthier S, Verreault R, Mc-Dowell I: Progression of impairment in patients with vascular cognitive impairment without dementia. Neurology 2001;57:714-716.
39. Stanek KM, Gunstad J, Paul RH, Poppas A, Jefferson AL, Sweet LH, Hoth KF, Haley AP, Forman DE, Cohen RA: Longitudinal cognitive performance in older adults with cardiovascular disease: evidence for improvement in heart failure. J Cardiovasc Nurs 2009;24:192-197.
40. Selnes OA, Grega MA, Bailey MM, Pham LD, Zeger SL, Baumgartner WA, McKhann GM: Cognition 6 years after surgical or medical therapy for coronary artery disease. Ann Neurol 2008;63:581-590.
41. Cohen RA, Poppas A, Forman DE, Hoth KF, Haley AP, Gunstad J, Jefferson AL, Tate DF, Paul RH, Sweet LH, Ono M, Jerskey BA, Gerhard-Herman M: Vascular and cognitive functions associated with cardiovascular disease in the elderly. J Clin Exp Neuropsychol 2008;31:96-110.
42. Haley AP, Forman DE, Poppas A, Hoth KF, Gunstad J, Jefferson AL, Paul RH, Ler AS, Sweet LH, Cohen RA: Carotid artery intimamedia thickness and cognition in cardiovascular disease. Int J Cardiol 2007;121:148-154.
43. Haley AP, Sweet LH, Gunstad J, Forman DE, Poppas A, Paul RH, Tate DF, Cohen RA: Verbal working memory and atherosclerosis in patients with cardiovascular disease: an fMRI study. J Neuroimaging 2007;17:227-233.
44. Hoth KF, Haley AP, Gunstad J, Paul RH, Poppas A, Jefferson AL, Tate DF, Ono M, Jerskey BA, Cohen RA: Elevated C-reactive protein is related to cognitive decline in older adults with cardiovascular disease. J Am Geriatr Soc 2008;56:1898-1903.
45. Gunstad J, Poppas A, Smeal S, Paul RH, Tate DF, Jefferson AL, Forman DE, Cohen RA: Relation of brain natriuretic peptide levels to cognitive dysfunction in adults 1 55 years of age with cardiovascular disease. Am J Cardiol 2006;98:538-540.
46. Gunstad J, Bausserman L, Paul RH, Tate DF, Hoth K, Poppas A, Jefferson AL, Cohen RA: C-reactive protein, but not homocysteine, is related to cognitive dysfunction in older adults with cardiovascular disease. J Clin Neurosci 2006;13:540-546.
47. de Jager CA: Changes over time in memory, processing speed and clock drawing tests help to discriminate between vascular cognitive impairment, mild cognitive impairment and Alzheimer's disease. Neurol Res 2004;26:481-487.
48. Wentzel C, Rockwood K, MacKnight C, Hachinski V, Hogan DB, Feldman H, Ostbye T, Wolfson C, Gauthier S, Verreault R, Mc-Dowell I: Progression of impairment in patients with vascular cognitive impairment without dementia. Neurology 2001;57:714-716.
49. Stanek KM, Gunstad J, Paul RH, Poppas A, Jefferson AL, Sweet LH, Hoth KF, Haley AP, Forman DE, Cohen RA: Longitudinal cognitive performance in older adults with cardiovascular disease: evidence for improvement in heart failure. J Cardiovasc Nurs 2009;24:192-197.
50. Selnes OA, Grega MA, Bailey MM, Pham LD, Zeger SL, Baumgartner WA, McKhann GM: Cognition 6 years after surgical or medical therapy for coronary artery disease. Ann Neurol 2008;63:581-590.
51. Cohen RA, Poppas A, Forman DE, Hoth KF, Haley AP, Gunstad J, Jefferson AL, Tate DF, Paul RH, Sweet LH, Ono M, Jerskey BA, Gerhard-Herman M: Vascular and cognitive functions associated with cardiovascular disease in the elderly. J Clin Exp Neuropsychol 2008;31:96-110.
52. Haley AP, Forman DE, Poppas A, Hoth KF, Gunstad J, Jefferson AL, Paul RH, Ler AS, Sweet LH, Cohen RA: Carotid artery intimamedia thickness and cognition in cardiovascular disease. Int J Cardiol 2007;121:148-154.
53. Haley AP, Sweet LH, Gunstad J, Forman DE, Poppas A, Paul RH, Tate DF, Cohen RA: Verbal working memory and atherosclerosis in patients with cardiovascular disease: an fMRI study. J Neuroimaging 2007;17:227-233.
54. Hoth KF, Haley AP, Gunstad J, Paul RH, Poppas A, Jefferson AL, Tate DF, Ono M, Jerskey BA, Cohen RA: Elevated C-reactive protein is related to cognitive decline in older adults with cardiovascular disease. J Am Geriatr Soc 2008;56:1898-1903.
55. Gunstad J, Poppas A, Smeal S, Paul RH, Tate DF, Jefferson AL, Forman DE, Cohen RA: Relation of brain natriuretic peptide levels to cognitive dysfunction in adults 155 years of age with cardiovascular disease. Am J Cardiol 2006;98:538-540.
56. Gunstad J, Bausserman L, Paul RH, Tate DF, Hoth K, Poppas A, Jefferson AL, Cohen RA: C-reactive protein, but not homocysteine, is related to cognitive dysfunction in older adults with cardiovascular disease. J Clin Neurosci 2006;13:540-546.
57. de Jager CA: Changes over time in memory, processing speed and clock drawing tests help to discriminate between vascular cognitive impairment, mild cognitive impairment and Alzheimer's disease. Neurol Res 2004;26:481-487.
58. Wentzel C, Rockwood K, MacKnight C, Hachinski V, Hogan DB, Feldman H, Ostbye T, Wolfson C, Gauthier S, Verreault R, Mc-Dowell I: Progression of impairment in patients with vascular cognitive impairment without dementia. Neurology 2001;57:714-716.
59. Stanek KM, Gunstad J, Paul RH, Poppas A, Jefferson AL, Sweet LH, Hoth KF, Haley AP, Forman DE, Cohen RA: Longitudinal cognitive performance in older adults with cardiovascular disease: evidence for improvement in heart failure. J Cardiovasc Nurs 2009;24:192-197.
60. Selnes OA, Grega MA, Bailey MM, Pham LD, Zeger SL, Baumgartner WA, McKhann GM: Cognition 6 years after surgical or medical therapy for coronary artery disease. Ann Neurol 2008;63:581-590.
61. Hernandez F Jr, Brown JR, Likosky DS, Clough RA, Hess AL, Roth RM, Ross CS, Whited CM, O'Connor GT, Klemperer JD: Neurocognitive outcomes of off-pump versus on-pump coronary artery bypass: a prospective randomized controlled trial. Ann Thorac Surg 2007;84:1897-1903.
62. Newman MF, Kirchner JL, Phillips-Bute B, Gaver V, Grocott H, Jones RH, Mark DB, Reves JG, Blumenthal JA: Longitudinal assessment of neurocognitive function after coronary-artery bypass surgery. N Engl J Med 2001;344:395-402.
63. Lezak MD, Howieson DB, Loring DW: Neuropsychological Assessment, ed 4. New York, Oxford University Press, 2004.
64. Singer JD, Willett JB: Applied Longitudinal Data Analysis. New York, Oxford University Press, 2003.
65. Guo Z, Viitanen M, Winblad B: Clinical correlates of low blood pressure in very old people: the importance of cognitive impairment. J Am Geriatr Soc 1997;45:701-705.
66. Almeida OP, Flicker L: The mind of a failing heart: a systematic review of the association between congestive heart failure and cognitive functioning. Intern Med J 2001;31:290-295.
67. Selnes OA, Grega MA, Borowicz LM Jr, Barry S, Zeger S, Baumgartner WA, McKhann GM: Cognitive outcomes three years after coronary artery bypass surgery: a comparison of on-pump coronary artery bypass graft surgery and nonsurgical controls. Ann Thorac Surg 2005;79:1201-1209.
68. Jefferson AL, Tate DF, Poppas A, Brickman AM, Paul RH, Gunstad J, Cohen RA: Lower cardiac output is associated with greater white matter hyperintensities in older adults with cardiovascular disease. J Am Geriatr Soc 2007;55:1044-1048.
69. Roman GC: Brain hypoperfusion: a critical factor in vascular dementia. Neurol Res 2004;26:454-458.
70. Almeida OP, Tamai S: Congestive heart failure and cognitive functioning amongst older adults. Arq Neuropsiquiatr 2001;59:324-329.
71. Bennett SJ, Sauve MJ: Cognitive deficits in patients with heart failure: a review of the literature. J Cardiovasc Nurs 2003;18:219-242.
72. Blumenthal JA, Madden DJ, Burker EJ, Croughwell N, Schniebolk S, Smith R, White WD, Hlatky M, Reves JG: A preliminary study of the effects of cardiac procedures on cognitive performance. Int J Psychosom 1991;38:13-16.
73. van Dijk D, Keizer AM, Diephuis JC, Durand C, Vos LJ, Hijman R: Neurocognitive dysfunction after coronary artery bypass surgery: a systematic review. J Thorac Cardiovasc Surg 2000;120:632-639.
74. Cook DJ, Huston J 3rd, Trenerry MR, Brown RD Jr, Zehr KJ, Sundt TM 3rd: Postcardiac surgical cognitive impairment in the aged using diffusion-weighted magnetic resonance imaging. Ann Thorac Surg 2007;83:1389-1395.
75. Hoth KF, Poppas A, Moser DJ, Paul RH, Cohen RA: Cardiac dysfunction and cognition in older adults with heart failure. Cogn Behav Neurol 2008;21:65-72.
76. Almeida OP, Tamai S: Clinical treatment reverses attentional deficits in congestive heart failure. BMC Geriatr 2001;1:2.
77. Zuccala G, Onder G, Pedone C, Carosella L, Pahor M, Bernabei R, Cocchi A: Hypotension and cognitive impairment: selective association in patients with heart failure. Neurology 2001;57:1986-1992.
78. Pullicino PM, Hart J: Cognitive impairment in congestive heart failure? Embolism versus hypoperfusion. Neurology 2001;57:1945-1946.
79. Beer C, Ebenezer E, Fenner S, Lautenschlager NT, Arnolda L, Flicker L, Almeida OP: Contributors to cognitive impairment in congestive heart failure: a pilot case-control study. Intern Med J 2009;39:600-605.
80. Zuccala G, Marzetti E, Cesari M, Lo Monaco MR, Antonica L, Cocchi A, Carbonin P, Bernabei R: Correlates of cognitive impairment among patients with heart failure: results of a multicenter survey. Am J Med 2005;118:496-502.
81. Ferrari R, Bachetti T, Agnoletti L, Comini L, Curello S: Endothelial function and dysfunction in heart failure. Eur Heart J 1998;19(suppl G): G41-G47.
82. Hoth KF, Tate DF, Poppas A, Forman DE, Gunstad J, Moser DJ, Paul RH, Jefferson AL, Haley AP, Cohen RA: Endothelial function and white matter hyperintensities in older adults with cardiovascular disease. Stroke 2007;38:308-312.
83. Selnes OA, Grega MA, Bailey MM, Pham L, Zeger S, Baumgartner WA, McKhann GM: Neurocognitive outcomes 3 years after coronary artery bypass graft surgery: a controlled study. Ann Thorac Surg 2007;84:1885-1896.
84. Shenkin SD, Bastin ME, Macgillivray TJ, Deary IJ, Starr JM, Rivers CS, Wardlaw JM: Cognitive correlates of cerebral white matter lesions and water diffusion tensor parameters in community-dwelling older people. Cerebrovasc Dis 2005;20:310-318.
85. Kalaria RN: Small vessel disease and Alzheimer's dementia: pathological considerations. Cerebrovasc Dis 2002;13(suppl 2):48-52.
86. Silbert LC, Nelson C, Howieson DB, Moore MM, Kaye JA: Impact of white matter hyperintensity volume progression on rate of cognitive and motor decline. Neurology 2008;71:108-113.
87. Jokinen H, Kalska H, Ylikoski R, Madureira S, Verdelho A, van der Flier WM, Scheltens P, Barkhof F, Visser MC, Fazekas F, Schmidt R, O'Brien J, Waldemar G, Wallin A, Chabriat H, Pantoni L, Inzitari D, Erkinjuntti T: Longitudinal cognitive decline in subcortical ischemic vascular disease - the LADIS Study. Cerebrovasc Dis 2009;27:384-391.